#BEGIN_DRUGCARD DB02182

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C34H34FeN4O4

# Chemical_IUPAC_Name:
(1R)-4,20-bis(2-carboxyethyl)-9-ethenyl-14-ethyl-5,10,15,19-tetramethyl-2$l^{5},22,23$l^{5},25-tetraaza-1-ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-2,4,6,8,10,12,14,16(23),17,19,21(24)-undecaene-2,23-bis(ylium)

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe)

# HET_ID:
HEB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C34H36N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h8,13-16H,2,7,9-12H2,1,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+4/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;

# InChI_Key:
InChIKey=NQJHVSISPZOPNZ-RGGAHWMASA-L

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2182

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
618.503

# Molecular_Weight_Mono:
618.192947729

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QQ3

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.19

# Predicted_LogS:
-5.5

# Predicted_Water_Solubility:
1.98e-03 g/l

# Primary_Accession_No:
DB02182

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
4633680

# PubChem_Substance_ID:
46508488

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01721

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCC1=C(C)C2=[N+]3C1=CC1=C(C)C(C=C)=C4C=C5C(C)=C(CCC(O)=O)C6=[N+]5[Fe@@]3(N3C(=C2)C(C)=C(CCC(O)=O)C3=C6)N14

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:52 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
S74736

# Drug_Target_1_GenBank_ID_Protein:
241593

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cybC

# Drug_Target_1_Gene_Sequence:
>387 bp
ATGCGTAAAAGCCTGTTAGCTATTCTTGCAGTCTCCTCGTTGGTATTCAGTTCTGCGTCG
TTTGCCGCTGATCTTGAAGACAATATGGAAACCCTCAACGACAATTTAAAAGTGATCGAA
AAAGCGGATAACGCGGCGCAAGTCAAAGACGCGTTAACGAAGATGCGCGCCGCAGCCCTG
GATGCGCAAAAAGCAACGCCGCCGAAGCTCGAAGATAAATCACCGGACAGCCCGGAAATG
AAAGATTTCCGCCACGGTTTCGACATTCTGGTCGGTCAGATTGACGACGCGCTGAAGCTG
GCAAATGAAGGTAAAGTAAAAGAAGCGCAGGCTGCTGCAGAGCAACTGAAAACGACCCGC
AACGCCTATCACCAGAAGTATCGTTAA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
10393541	Arnesano F, Banci L, Bertini I, Faraone-Mennella J, Rosato A, Barker PD, Fersht AR: The solution structure of oxidized Escherichia coli cytochrome b562. Biochemistry. 1999 Jul 6;38(27):8657-70.
11669612	Assfalg M, Banci L, Bertini I, Ciofi-Baffoni S, Barker PD: (15)N backbone dynamics of ferricytochrome b(562): comparison with the reduced protein and the R98C variant. Biochemistry. 2001 Oct 30;40(43):12761-71.
11914078	Springs SL, Bass SE, Bowman G, Nodelman I, Schutt CE, McLendon GL: A multigeneration analysis of cytochrome b(562) redox variants: evolutionary strategies for modulating redox potential revealed using a library approach. Biochemistry. 2002 Apr 2;41(13):4321-8.
1761034	Nikkila H, Gennis RB, Sligar SG: Cloning and expression of the gene encoding the soluble cytochrome b562 of Escherichia coli. Eur J Biochem. 1991 Dec 5;202(2):309-13.
368073	Mathews FS, Bethge PH, Czerwinski EW: The structure of cytochrome b562 from Escherichia coli at 2.5 A resolution. J Biol Chem. 1979 Mar 10;254(5):1699-706.
4882876	Itagaki E, Hager LP: The amino acid sequence of cytochrome b562 of Escherichia coli. Biochem Biophys Res Commun. 1968 Sep 30;32(6):1013-9.
7031264	Lederer F, Glatigny A, Bethge PH, Bellamy HD, Matthew FS: Improvement of the 2.5 A resolution model of cytochrome b562 by redetermining the primary structure and using molecular graphics. J Mol Biol. 1981 Jun 5;148(4):427-48.
7610040	Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL, Blattner FR: Analysis of the Escherichia coli genome VI: DNA sequence of the region from 92.8 through 100 minutes. Nucleic Acids Res. 1995 Jun 25;23(12):2105-19.
7723042	Hamada K, Bethge PH, Mathews FS: Refined structure of cytochrome b562 from Escherichia coli at 1.4 A resolution. J Mol Biol. 1995 Apr 14;247(5):947-62.
8499452	Trower MK: PCR cloning, sequence analysis and expression of the cybC genes encoding soluble cytochrome b-562 from Escherichia coli B strain OP7 and K strain NM522. Biochim Biophys Acta. 1993 Jun 10;1143(1):109-11.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3670

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
14061

# Drug_Target_1_Name:
Soluble cytochrome b562 precursor

# Drug_Target_1_Number_of_Residues:
128

# Drug_Target_1_PDB_ID:
1QPU

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF07361	Cytochrom_B562

# Drug_Target_1_Protein_Sequence:
>Soluble cytochrome b562 precursor
MRKSLLAILAVSSLVFSSASFAADLEDNMETLNDNLKVIEKADNAAQVKDALTKMRAAAL
DAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTR
NAYHQKYR

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-22

# Drug_Target_1_Specific_Function:
Electron-transport protein of unknown function

# Drug_Target_1_SwissProt_ID:
P0ABE7

# Drug_Target_1_SwissProt_Name:
C562_ECOLX

# Drug_Target_1_Synonyms:
Cytochrome b-562

# Drug_Target_1_Theoretical_pI:
6.54

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02182
